RxDoctor Payments Data

Izabela Plucinska

Family · Arnold, MDNPI 1720070626

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 34.6% of the total. Reporting peaked in 2022 at $899 and has fallen 98.2% since, to $16 in 2024.

$1,890in general payments, 2019–2025

Across 107 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$655
  • Novo Nordisk$225
  • Pfizer$133
  • Lilly USA, LLC$119
  • Merck$68
  • GSK$57
  • plus $632 from 22 others

What the payments were for

  • Food & beverage$1,890100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,890 in reported general payments places this provider in the 80th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland →

Other family in Arnold

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →